RMD · NYQ S&P 500

ResMed Inc.

Healthcare · Medical Instruments & Supplies

$234.11 −$1.63 (−0.69%) today

Closing price on Nov 10, 2026 · Source: Yahoo Finance

Consensus of 20 analysts

Buy

Median price target $270.00 +15.3%

Open: $234.49
Day range: 231.13 – $235.85
52-week range: 180.27 – $277.67
Volume: 1,157,918
Market cap: $32,929M
P/E (TTM): 21.3x
EPS (TTM): $10.98
EPS est. FY 2027: $12.14
P/E est. FY 2027: 19.3x
Dividend yield: 1.1%
Beta: 0.76
Payout: 22%

ResMed financials

Q3 2026 results, quarter ended Sep 30, 2026

Metric	Q3 2026	1-year change
Total revenue	$1,415M	+5.9%
Net income	$418M	+20.0%
Earnings per share	$2.92	+23.2%
Net margin	29.6%	+3.5 pp
Free cash flow	$371M	−9.8%
Debt / equity	0.10	−25.8%

Revenue and net income ($M)

Total revenueNet income

Quarter	Total revenue	Net income
Q3 2025	$1,336M	$349M
Q4 2025	$1,423M	$393M
Q1 2026	$1,431M	$399M
Q2 2026	$1,464M	$383M
Q3 2026	$1,415M	$418M

ResMed earnings per share (EPS)

Consensus estimates

Period	EPS est.	1-year change
Current quarterQ4 2026 · Analysts: 13	$2.9902.93 – 3.13	+6.4%$2.810
Next quarterQ1 2027 · Analysts: 13	$3.0563.02 – 3.10	+6.9%$2.860
Current yearFY 2027 · Analysts: 21	$12.14112.02 – 12.23	+8.7%$11.170
Next yearFY 2028 · Analysts: 21	$13.22612.71 – 13.73	+8.9%$12.141

Forward P/E: 19.3x (FY 2027) and 17.7x (FY 2028) at the current price.

Actual and estimated EPS ($)

Actual EPSEstimated EPS

Quarter	Actual EPS	Estimated EPS
Q3 2025	$2.370	—
Q4 2025	$2.810	$2.724
Q1 2026	$2.860	$2.800
Q2 2026	$2.950	$2.893
Q3 2026	$2.910	$2.673
Q4 2026	—	$2.990
Q1 2027	—	$3.056

Year	Actual EPS	Estimated EPS
FY 2022	$5.300	—
FY 2023	$6.090	—
FY 2024	$6.920	—
FY 2026	$10.430	—
FY 2027	—	$12.141
FY 2028	—	$13.226

EPS trend

Quarter	EPS	YoY change
Q1 2027Estimated	$3.056	+6.8%
Q4 2026Estimated	$2.990	+6.4%
Q3 2026	$2.910est. $2.673 · surprise +8.9%	+22.8%
Q2 2026	$2.950est. $2.893 · surprise +2.0%	n/a
Q1 2026	$2.860est. $2.800 · surprise +2.2%	n/a
Q4 2025	$2.810est. $2.724 · surprise +3.2%	n/a
Q3 2025	$2.370	n/a

Year	EPS	Annual change
FY 2028Estimated	$13.226	+8.9%
FY 2027Estimated	$12.141	+16.4%
FY 2026	$10.430	n/a
FY 2024	$6.920	+13.6%
FY 2023	$6.090	+14.9%
FY 2022	$5.300	n/a

Normalised EPS according to the analyst consensus collected by Yahoo Finance; it may differ from the reported EPS in the results table.

ResMed dividend

Yield and payments

Dividend yield (TTM)	1.1%
Forward yield (next 12m)	1.1%
Dividend per share (TTM)	$2.46
Forward dividend (next 12m)	$2.64
Payout (TTM)	22%
Last dividend	$0.66Aug 20, 2026
Next ex-dividend date	Nov 12, 2026

Dividend per share by year ($)

PaidEstimated

Year	Dividend per share
2019	$1.52
2020	$1.56
2021	$1.62
2022	$1.72
2023	$1.84
2024	$2.02
2025	$2.26
est. 12m	$2.64

ResMed forecasts

20 analyst ratings

Buy45% Hold50% Sell5%

Consensus: Buy · 9 buy, 10 hold, 1 sell

1-year price forecast

Share price Price target (high, median, low)

12-month price targets
Target	Price	Upside
High	$320.00	+36.7%
Median	$270.00	+15.3%
Low	$210.00	−10.3%

Monthly close (last 12 months)
Date	Close
Nov 28, 2025	$255.83
Dec 31, 2025	$240.87
Jan 30, 2026	$258.31
Feb 27, 2026	$256.26
Mar 31, 2026	$224.48
Apr 30, 2026	$213.81
May 29, 2026	$190.57
Jun 30, 2026	$194.88
Jul 31, 2026	$210.98
Aug 31, 2026	$240.10
Sep 30, 2026	$221.10
Oct 30, 2026	$229.94
Nov 10, 2026	$234.11

ResMed peers

Ticker	Company	Market cap ($M)	P/E	Price ($)	1-day change	52-week range
RMD	ResMed	32,929	21.3x	234.11	−0.69%	180.27277.67
ISRG	Intuitive Surgical	156,004	54.4x	450.04	−2.28%	328.57603.88
BDX	Becton Dickinson	57,912	42.0x	212.61	−1.23%	140.11216.74
WST	West Pharmaceutical Services	28,739	46.3x	412.55	−0.07%	223.83438.27
SOLV	Solventum	15,310	101.2x	90.08	−0.39%	62.3894.16
BAX	Baxter International	13,668	n/a	26.42	+0.04%	15.7330.00